Every day, I learn something new from my patients and colleagues. I am constantly inspired by the children we care for and their families.
Where I see patients (5)
Pre-and post-HSCT use of TKI therapy for fusion-driven B-ALL: A case series of five pediatric, adolescent and young adult patients.
Cancer reports (Hoboken, N.J.)
Osteosarcoma PDX-Derived Cell Line Models for Preclinical Drug Evaluation Demonstrate Metastasis Inhibition by Dinaciclib through a Genome-Targeted Approach.
Clinical cancer research : an official journal of the American Association for Cancer Research
UHRF1 is a mediator of KRAS driven oncogenesis in lung adenocarcinoma.